125 related articles for article (PubMed ID: 37024439)
1. Long Noncoding RNA AP000695.2 as a Novel Prognostic Biomarker for Gastric Cancer.
Cheng Y; Yi X; Fu S; Cheng J; Li W; Xu H
Discov Med; 2023 Feb; 35(174):28-35. PubMed ID: 37024439
[TBL] [Abstract][Full Text] [Related]
2. Identification and Construction of a Long Noncoding RNA Prognostic Risk Model for Stomach Adenocarcinoma Patients.
Zha Z; Zhang P; Li D; Liu G; Lu L
Dis Markers; 2021; 2021():8895723. PubMed ID: 33680217
[TBL] [Abstract][Full Text] [Related]
3. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
Ma B; Li Y; Ren Y
Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
[TBL] [Abstract][Full Text] [Related]
4. A prognostic 3-long noncoding RNA signature for patients with gastric cancer.
Cheng P
J Cell Biochem; 2018 Nov; 119(11):9261-9269. PubMed ID: 30074647
[TBL] [Abstract][Full Text] [Related]
5. Long Non-Coding RNA AP000695.2 Acts as a Novel Prognostic Biomarker and Regulates the Cell Growth and Migration of Lung Adenocarcinoma.
Wang C; Guo J; Jiang R; Wang C; Pan C; Nie Z; Jiang X
Front Mol Biosci; 2022; 9():895927. PubMed ID: 35685240
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
7. H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
Chen JS; Wang YF; Zhang XQ; Lv JM; Li Y; Liu XX; Xu TP
Neoplasma; 2016; 63(2):223-30. PubMed ID: 26774144
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.
Yuan CL; Li H; Zhu L; Liu Z; Zhou J; Shu Y
Neoplasma; 2016; 63(3):442-9. PubMed ID: 26925791
[TBL] [Abstract][Full Text] [Related]
9. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
10. LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration.
Ye Y; Ge O; Zang C; Yu L; Eucker J; Chen Y
Technol Cancer Res Treat; 2022; 21():15330338221080977. PubMed ID: 35254147
[No Abstract] [Full Text] [Related]
11. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer.
Wei J; Zeng Y; Gao X; Liu T
BMC Cancer; 2021 Nov; 21(1):1221. PubMed ID: 34774009
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Overall Survival in Gastric Cancer Using a Nine-lncRNA.
Cai C; Yang L; Tang Y; Wang H; He Y; Jiang H; Zhou K
DNA Cell Biol; 2019 Sep; 38(9):1005-1012. PubMed ID: 31335180
[TBL] [Abstract][Full Text] [Related]
13. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
14. TIMP2 is associated with prognosis and immune infiltrates of gastric and colon cancer.
Jian F; Yanhong J; Limeng W; Guoping N; Yiqing T; Hao L; Zhaoji P
Int Immunopharmacol; 2022 Sep; 110():109008. PubMed ID: 35792273
[TBL] [Abstract][Full Text] [Related]
15.
Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
[TBL] [Abstract][Full Text] [Related]
16. Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer.
Fei ZH; Yu XJ; Zhou M; Su HF; Zheng Z; Xie CY
Tumour Biol; 2016 Feb; 37(2):1983-93. PubMed ID: 26334618
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA microvascular invasion in hepatocellular carcinoma is an indicator of poor prognosis and a potential therapeutic target in gastric cancer.
Wang A; Du L; Jiang K; Kong Q; Zhang X; Li L
J Cancer Res Ther; 2019; 15(1):126-131. PubMed ID: 30880767
[TBL] [Abstract][Full Text] [Related]
18. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
Li W; Liu J; Zhao H
Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
[TBL] [Abstract][Full Text] [Related]
19. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
20. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis in gastric cancer: Evidence from published studies and followed up verification.
Duan F; Li Y; Feng Y; Niu G; Chai J; Wang K
Cancer Med; 2023 Feb; 12(4):4227-4235. PubMed ID: 36164273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]